Beth Shaz

Dr. Beth Shaz

Core Faculty

Beth Shaz

Degrees

MD, University of Michigan

BS, Cornell University

Beth Shaz, MD, MBA is the Deputy Director of Marcus Center for Cellular Cures (MC3). Dr. Shaz has 20+ years of experience in transfusion medicine and cellular therapies.  Dr. Shaz serves as Director of the Robertson GMP Laboratory, and as Co-Director of Duke’s Stem Cell Lab, Associate Director of the Carolinas Cord Blood Bank (CCBB), and supervises MC3’s clinical trials in adult populations. Dr. Shaz holds a primary appointment with the Department of Pathology as Professor. Her goals are to improve the health of our community and ensure equal access to safe and efficacious blood and biotherapies.

Dr. Shaz was most recently the Executive Vice President, Chief Medical and Scientific Officer of the New York Blood Center enterprises. In that role, Dr. Shaz directed all medical activities, including medical oversight of blood donation, hemophilia services, transfusion services, cellular therapy laboratory, bone marrow recruitment and donation, perioperative autologous services, and apheresis services. Dr. Shaz created and led Comprehensive Cell Solutions, whose goal was to develop cellular therapies. Prior to joining the New York Blood Center, Dr. Shaz was an Associate Professor at Emory University and directed the transfusion service at Grady Memorial Hospital, and before that, she was an Instructor at Harvard Medical School and Assistant Medical Director of the transfusion service and Medical Director of the transfusion/apheresis unit at Beth Israel Deaconess Medical Center.

Dr. Shaz is Past-President of AABB, a member of the Board of Directors of the Cord Blood Association, and has been a board member, committee chair and active committee member of the American Society for Apheresis. Dr. Shaz has published more than 160 peer-reviewed articles and has co-edited eight books. She is an Associate Editor of the journal Transfusion and was on the editorial board of the journal Blood. Dr. Shaz received her BS with Distinction in Chemical Engineering from Cornell University, her MD at University of Michigan Medical School, and her MBA in Healthcare Leadership at Empire State College, State University of New York. She completed her surgical internship at Georgetown University, and her pathology residency and blood banking / transfusion medicine Fellowship at Harvard Medical School.

Tobian AAR, Cohn CS, Shaz BH. COVID-19 convalescent plasma. Blood. 2022 Jul 21;140(3):196–207.

Cancelas JA, Genthe JR, Stolla M, Rugg N, Bailey SL, Nestheide S, et al. Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage. Transfusion. 2022 Jul 9;

Jacquot C, Tiberghien P, van den Hurk K, Ziman A, Shaz B, Apelseth TO, et al. Blood donor eligibility criteria for medical conditions: A BEST collaborative study. Vox Sang. 2022 Jul;117(7):929–36.